I lead the Computational Oncology group at Imperial College, based jointly between the Dept. of Computing and Division of Surgery & Cancer.
We are interested in mathematical and computational approaches to clinical problems, including the use of machine learning, computational argumentation and the use of clinical 'big data'. In particular, we are interested in improving access to and use of clinical data, with the aim of developing and applying computational techniques to these data.
We talk about our work on the lab blog. I currently supervise 5 PhD/ MD students, as well as MRes & MSc student projects. We are open to supervising UG student projects, but would encourage students to apply through schemes such as the RCR SURF program.
I have held several local & national positions. I was previously Clinical Lead for QA at NCRAS and a Macmillan Advisor on Cancer data. I currently chair the RCR QI & Audit committee for clinical oncology. I am on the PC for IEEE CBMS
Clinically, I deliver radiotherapy and chemotherapy to patient with brain and spinal tumours, including IMRT and stereotactic radiotherapy. My clinical work is based at Charing Cross hospital, and we have a strong clinical-research link, including the BrainWear trial.
et al., 2022, Imaging in patients with glioblastoma: A national cohort study, Neuro-oncology Practice, Vol:9, ISSN:2054-2585, Pages:487-495
et al., 2022, FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial., Bmj Open, Vol:12
et al., 2022, Launch of the UK SABR Consortium Pelvic Stereotactic Ablative Radiotherapy Re-irradiation Guidelines and National Audit., Clin Oncol (r Coll Radiol)
Rozati H, Williams M, 2022, SURVIVAL OUTCOMES OF STEREOTACTIC RADIOTHERAPY FOR TEN OR MORE BRAIN METASTASES, OXFORD UNIV PRESS INC, Pages:9-9, ISSN:1522-8517
et al., 2022, THE COST OF INPATIENT CARE FOR ADULT PRIMARY BRAIN TUMOUR PATIENTS IN ENGLAND, OXFORD UNIV PRESS INC, ISSN:1522-8517